LDL, HDL and endocrine-related cancer: From pathogenic mechanisms to therapies-Reference-Cited by-同舟云学术

LDL, HDL and endocrine-related cancer: From pathogenic mechanisms to therapies

Published:2021-08 Issue: Volume:73 Page:134-157
ISSN:1044-579X
Container-title:Seminars in Cancer Biology
language:en
Short-container-title:Seminars in Cancer Biology

Author:

Revilla Giovanna,Cedó Lídia,Tondo Mireia,Moral Antonio,Pérez José Ignacio,Corcoy Rosa,Lerma Enrique,Fuste Victoria,Reddy Srivinasa T.,Blanco-Vaca Francisco,Mato Eugènia,Escolà-Gil Joan Carles^ORCID

Funder

Instituto de Salud Carlos III

Publisher

Elsevier BV

Subject

Cancer Research

Reference335 articles.

1. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities;Huang;Nat Metab.,2020

2. WHO Classification of Tumours of Endocrine Organs;Lloyd,2017

3. Inhibition of intestinal cholesterol absorption by ezetimibe in humans;Sudhop;Circulation,2002

4. Regulation of cholesterol homeostasis;van der Wulp;Mol. Cell. Endocrinol.,2013

5. Retrospective on cholesterol homeostasis: the central role of scap;Brown;Annu. Rev. Biochem.,2018

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A natural nano-platform: Advances in drug delivery system with recombinant high-density lipoprotein;CHINESE CHEM LETT;2024

2. A natural nano-platform: Advances in drug delivery system with recombinant high-density lipoprotein;Chinese Chemical Letters;2024-11

3. Associations Between Metabolic Obesity Phenotypes and Pathological Characteristics of Papillary Thyroid Carcinoma;Endocrine Practice;2024-07

4. Apolipoproteins in Health and Disease;International Journal of Molecular Sciences;2024-06-27

5. Is STARD3 A New Biomarker for Breast Cancer?;European Journal of Breast Health;2024-04-01